본문 바로가기
KERD
논문KCI 등재

Cell Death and Liver Disease

Hidekazu Tsukamoto|Satoka Aizawa|Gurmehr Brar
거트앤리버 소화기연관학회협의회|2020.01|Gut and Liver|제14권 제1호|pp. 20-29

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

ApoptosisFerroptosisNecroptosisPyroptosis

초록

Cell death is now reclassified into several types based on the mechanisms and morphologic phenotype. Understanding of such classifications offers insights into the pathogenesis of liver disease, as well as diagnostic or therapeutic implications. Apoptosis is recognized relatively easily due to its unique morphology, but lytic cell death may occur in the form of accidental necrosis, mitochondria permeability transition-driven necrosis, necroptosis, pyroptosis, ferroptosis, and parthanatos. The cell may be engulfed by neighboring cells due to a loss of integrin signaling or cancer cell competition by entosis, a type of cell death. The classification also includes mechanistically termed cell death such as autophagy-dependent cell death and lysosome-dependent cell death. These different types of cell death may occur uniquely in certain liver diseases but may coexist in the evolution of the disease. They occur in parenchymal and non-parenchymal liver cells, as well as inflammatory cells, causing distinct pathologic consequences. This review briefly covers the recently revised classifications of cell death and discusses their relevance to liver diseases of different etiologies.

Abstract

Cell death is now reclassified into several types based on the mechanisms and morphologic phenotype. Understanding of such classifications offers insights into the pathogenesis of liver disease, as well as diagnostic or therapeutic implications. Apoptosis is recognized relatively easily due to its unique morphology, but lytic cell death may occur in the form of accidental necrosis, mitochondria permeability transition-driven necrosis, necroptosis, pyroptosis, ferroptosis, and parthanatos. The cell may be engulfed by neighboring cells due to a loss of integrin signaling or cancer cell competition by entosis, a type of cell death. The classification also includes mechanistically termed cell death such as autophagy-dependent cell death and lysosome-dependent cell death. These different types of cell death may occur uniquely in certain liver diseases but may coexist in the evolution of the disease. They occur in parenchymal and non-parenchymal liver cells, as well as inflammatory cells, causing distinct pathologic consequences. This review briefly covers the recently revised classifications of cell death and discusses their relevance to liver diseases of different etiologies.

참고문헌 (78)

  1. Galluzzi L, "Molecular mechanisms of cell death : recommendations of the Nomenclature Committee on Cell Death 2018", Cell Death Differ, 25, pp.486~541 (2018)
  2. Wang S, "A mechanistic review of cell death in alcohol-induced liver injury", Alcohol Clin Exp Res, 40, pp.1215~1223 (2016)
  3. Luedde T, "Cell death and cell death responses in liver disease : mechanisms and clinical relevance", Gastroenterology, 147, pp.765~783 (2014)
  4. Canbay A, "Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression", Hepatology, 38, pp.1188~1198 (2003)
  5. Canbay A, "Fas enhances fibrogenesis in the bile duct ligated mouse : a link between apoptosis and fibrosis", Gastroenterology, 123, pp.1323~1330 (2002)
  6. Elmore S, "Apoptosis : a review of programmed cell death", Toxicol Pathol, 35, pp.495~516 (2007)
  7. Wang C, "The role of mitochondria in apoptosis*", Annu Rev Genet, 43, pp.95~118 (2009)
  8. Schwabe RF, "Apoptosis and necroptosis in the liver : a matter of life and death", Nat Rev Gastroenterol Hepatol, 15, pp.738~752 (2018)
  9. Plissonnier ML, "Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A(UNC5A)and the hepatitis C virus", Oncogene, 36, pp.6712~6724 (2017)
  10. Kendall TJ, "p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis", Hepatology, 49, pp.901~910 (2009)
  11. Passino MA, "Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR", Science, 315, pp.1853~1856 (2007)
  12. Su F, "Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha", Proc Natl Acad Sci U S A, 94, pp.8744~8749 (1997)
  13. Terradillos O, "p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro", Oncogene, 17, pp.2115~2123 (1998)
  14. Shirakata Y, "Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential", J Biol Chem, 278, pp.22071~22078 (2003)
  15. Kim KH, "Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of deathinducing signal", EMBO J, 22, pp.2104~2116 (2003)
  16. Elmore LW, "Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis", Proc Natl Acad Sci U S A, 94, pp.14707~14712 (1997)
  17. Diao J, "X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK", JNK pathway, 2001, pp.276, 8328~8340
  18. Shin GC, "Hepatitis B virus-triggered autophagy targets TNFRSF10B", death receptor 5 for degradation to limit TNFSF10, Autophagy, pp.2016, 12[DOI]
  19. Huang XY, "Hepatitis B Virus X protein elevates Parkin-mediated mitophagy through Lon Peptidase in starvation", Exp Cell Res, 368, pp.75~83 (2018)
  20. Ramachandran A, "Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury", Free Radic Res, 45, pp.156~164 (2011)
  21. LoGuidice A, "Acetaminophen overdose-induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D-regulated permeability transition", Hepatology, 54, pp.969~978 (2011)
  22. Wang X, "Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis", Hepatology, 68, pp.62~77 (2018)
  23. Laker RC, "The mitochondrial permeability transition pore regulator cyclophilin D exhibits tissue-specific control of metabolic homeostasis", PLoS One, 11, pp.e0167910~ (2016)
  24. Teodoro JS, "Indirubin and NAD(+)prevent mitochondrial ischaemia", reperfusion damage in fatty livers, 2018, pp.48, e12932~
  25. Zhong Z, "Acute ethanol causes hepatic mitochondrial depolarization in mice : role of ethanol metabolism", PLoS One, 9, pp.e91308~ (2014)
  26. King AL, "Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice", Am J Physiol Gastrointest Liver Physiol, 306, pp.G265~G277 (2014)
  27. Roychowdhury S, "Absence of receptor interacting protein kinase 3 prevents ethanolinduced liver injury", Hepatology, 57, pp.1773~1783 (2013)
  28. Seehawer M, "Necroptosis microenvironment directs lineage commitment in liver cancer", Nature, 562, pp.69~75 (2018)
  29. Conos SA, "Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner", Proc Natl Acad Sci U S A, 114, pp.E961~E969 (2017)
  30. Roychowdhury S, "Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury", Hepatology, 64, pp.1518~1533 (2016)
  31. Xie Y, "Ferroptosis : process and function", Cell Death Differ, 23, pp.369~379 (2016)
  32. Wang H, "Characterization of ferroptosis in murine models of hemochromatosis", Hepatology, 66, pp.449~465 (2017)
  33. Lőrincz T, "Ferroptosis is involved in acetaminophen induced cell death", Pathol Oncol Res, 21, pp.1115~1121 (2015)
  34. Biasiotto G, "Iron and neurodegeneration : is ferritinophagy the link", Mol Neurobiol, 53, pp.5542~5574 (2016)
  35. Woodhoo A, "Human antigen R contributes to hepatic stellate cell activation and liver fibrosis", Hepatology, 56, pp.1870~1882 (2012)
  36. Zhang Z, "Activation of ferritinophagy is required for the RNA-binding protein ELAVL1", HuR to regulate ferroptosis in hepatic stellate cells, 2018, pp.14, 2083~2103
  37. Cookson BT, "Pro-inflammatory programmed cell death", Trends Microbiol, 9, pp.113~114 (2001)
  38. Kayagaki N, "Non-canonical inflammasome activation targets caspase-11", Nature, 479, pp.117~121 (2011)
  39. Kayagaki N, "Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling", Nature, 526, pp.666~671 (2015)
  40. Ding J, "Pore-forming activity and structural autoinhibition of the gasdermin family", Nature, 535, pp.111~116 (2016)
  41. Liu X, "Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores", Nature, 535, pp.153~158 (2016)
  42. Mulvihill E, "Mechanism of membrane pore formation by human gasdermin-D", EMBO J, 37, pp.e98321~ (2018)
  43. Mathurin P, "Trends in the management and burden of alcoholic liver disease", J Hepatol, 62(1 Suppl), pp.S38~S46 (2015)
  44. Mann RE, "The epidemiology of alcoholic liver disease", Alcohol Res Health, 27, pp.209~219 (2003)
  45. Lucey MR, "Alcoholic hepatitis", N Engl J Med, 360, pp.2758~2769 (2009)
  46. Basra S, "Definition, epidemiology and magnitude of alcoholic hepatitis", World J Hepatol, 3, pp.108~113 (2011)
  47. Marroni CA, "Liver transplantation and alcoholic liver disease : history, controversies, and considerations", World J Gastroenterol, 24, pp.2785~2805 (2018)
  48. Mathurin P, "Early liver transplantation for severe alcoholic hepatitis", N Engl J Med, 365, pp.1790~1800 (2011)
  49. Khanova E, "Pyroptosis by caspase11", 4-gasdermin-D pathway in alcoholic hepatitis in mice and patients, 2018, pp.67, 1737~1753
  50. Xu B, "Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice", J Hepatol, 8, pp.773~782 (2018)
  51. Kofahi HM, "Hepatitis C virus infection of cultured human hepatoma cells causes apoptosis and pyroptosis in both infected and bystander cells", Sci Rep, 6, pp.37433~ (2016)
  52. Palacios-Macapagal D, "Cutting edge : eosinophils undergo caspase-1-mediated pyroptosis in response to necrotic liver cells", J Immunol, 199, pp.847~853 (2017)
  53. Lan P, "TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury", J Clin Invest, 127, pp.2222~2234 (2017)
  54. Marin V, "Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients", J Hepatol, 67, pp.1018~1025 (2017)
  55. Wang Y, "A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose)polymerase-1", Science, 354, pp.aad6872~ (2016)
  56. Park EJ, "β-Lapachone induces programmed necrosis through the RIP1-PARP-AIFdependent pathway in human hepatocellular carcinoma SK-Hep1cells", Cell Death Dis, 5, pp.e1230~ (2014)
  57. Jouan-Lanhouet S, "TRAIL induces necroptosis involving RIPK1", RIPK3-dependent PARP-1activation, 2012, pp.19, 2003~2014
  58. Sun Q, "Competition between human cells by entosis", Cell Res, 24, pp.1299~1310 (2014)
  59. Hamann JC, "Entosis is induced by glucose starvation", Cell Rep, 20, pp.201~210 (2017)
  60. Sierro F, "Suicidal emperipolesis : a process leading to cell-in-cell structures, T cell clearance and immune homeostasis", Curr Mol Med, 15, pp.819~827 (2015)
  61. Shi J, "Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-beta-dependent emperipolesis in HBV cirrhotic patients", Sci Rep, 7, pp.44544~ (2017)
  62. Wang Y, "Citreoviridin induces autophagydependent apoptosis through lysosomal-mitochondrial axis in human liver HepG2 cells", Toxins(Basel), 7, pp.3030~3044 (2015)
  63. Guicciardi ME, "cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis", Am J Physiol Gastrointest Liver Physiol, 292, pp.G1337~G1346 (2007)
  64. Li Z, "The lysosomalmitochondrial axis in free fatty acid-induced hepatic lipotoxicity", Hepatology, 47, pp.1495~1503 (2008)
  65. Kharbanda KK, "Ethanol consumption reduces the proteolytic capacity and protease activities of hepatic lysosomes", Biochim Biophys Acta, 1245, pp.421~429 (1995)
  66. Chao X, "Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice", Gastroenterology, 155, pp.865~879 (2018)
  67. Kreuzaler PA, "Stat3 controls lysosomal-mediated cell death in vivo", Nat Cell Biol, 13, pp.303~309 (2011)
  68. Annibaldi A, "Ubiquitinmediated regulation of RIPK1 kinase activity independent of IKK and MK2", Mol Cell, 69, pp.566~580 (2018)
  69. Hitomi J, "Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway", Cell, 135, pp.1311~1323 (2008)
  70. Chung H, "NLRP3 regulates a noncanonical platform for caspase-8 activation during epithelial cell apoptosis", Cell Death Differ, 23, pp.1331~1346 (2016)
  71. Alvarez-Diaz S, "The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis", Immunity, 45, pp.513~526 (2016)
  72. O’Donnell MA, "Caspase 8 inhibits programmed necrosis by processing CYLD", Nat Cell Biol, 13, pp.1437~1442 (2011)
  73. Mascarenhas DP, "Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5", NLRC4, PLoS Pathog, pp.2017, 13[DOI]
  74. Wang Y, "Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin", Nature, 547, pp.99~103 (2017)
  75. Taabazuing CY, "Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages", Cell Chem Biol, 24, pp.507~514 (2017)
  76. Orozco S, "RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis", Cell Death Differ, 21, pp.1511~1521 (2014)
  77. Ting AT, "RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas", APO-1-initiated apoptosis, 1996, pp.15, 6189~6196
  78. Basu S, "Insulin-like growth factor receptor-1 and nuclear factor kappaB are crucial survival signals that regulate caspase-3-mediated lens epithelial cell differentiation initiation", J Biol Chem, 287, pp.8384~8397 (2012)

관련 논문AI추천

Diversity and complexity of cell death: a historical review배성진, 채영찬, Ha Ki-Tae, Kim Bo-Sung, Park Wonyoung, Ryu Dongryeol, Wei Shibo생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Programmed cell death in alcohol-associated liver diseaseLaura E. Nagy, Tatsunori Miyata대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제4호Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis배성진, Ha Ki-Tae, KARKI RAJENDRA, Lee Ein, Song Chang-Hyun생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Recent advances in cell deathHa Ki-Tae생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Entosis: the core mechanism and crosstalk with other cell death programsKim Sung Eun, Kim Sunghoon, Lee Donghyuk, Overholtzer Michael생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Mitochondria-associated programmed cell death as a therapeutic target for age-related diseaseGariani Karim, Ha Ki-Tae, Houtkooper Riekelt H., Jo Yunju, Kim Hyeon Ho, Lee In-Kyu, Nguyen Thanh T., Nguyen Thu Ha, Oh Chang-Myung, Park Kyu-Sang, Park Raekil, Park Wonyoung, Ryu Dongryeol, Shong Minho, Wei Shibo, Zhang Yan생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권

이 간행물의 다른 논문 (16건)

The Pros and Cons of Helicobacter pylori Treatment: A Focus on Cardiovascular MortalityByung-Wook Kim, Cheal Wung Huhpp. 1-2Trends in Healthcare Costs for Inflammatory Bowel Disease in South KoreaYoon Suk Jungpp. 3-4Bridging the Gap between Evidence and Real-World Practice for Liver Cancer Screening in South Korea오창모pp. 5-6Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel DiseaseHiroshi Nakasepp. 7-19Detecting Early Pancreatic Cancer: Current Problems and Future ProspectsHiroyuki Ono, Katsuhiko Uesaka, Hiroyuki Matsubayashi, Hirotoshi Ishiwatari, Keiko Sasakipp. 30-36
원문 보기